Filters

Human Recombinant (E.Coli) Purified Leptin binding domain

Human Recombinant (E.Coli) Purified Leptin binding domain size: 50 μg 333

Supplier ADI
Price 333
Size 50 μg
Contact us Ask Component cell markers and DNA bp. markers are genetic markerser genes or DNA sequenceswith selection audit
ELISA kit stock availabilityAvailable In Stock
ELISA's descriptionColi) Purified Leptin binding domain, Human Recombinant (E
CategoryRecombinant Protein
S typePurified protein
Antibody's host issee techfile
PurificationAffinity purified
Properties Depending on the epitopes used human ELISA kits can be cross reactive to many other species, Mainly analyzed are human serum, Modern , cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies, human cell culture supernatants and biological samples, plasma, primarily , saliva, urine,  , (Homo sapiens, Homo sapiens sapiens), Human proteins, humans , ssp
Gene ", Both hormones act on receptors in the , ELISA kits and peptides and antibodies are available, Leptin is opposed by the actions of the hormone , the ", &epsilon, &lambda,  ,  , &pi, &tau, (from , ) the ", Greek , Human or mouse Leptin , adipose cells , arcuate nucleus , by inhibiting hunger, energy balance , energy homeostasis, ghrelin, hormone , hunger hormone", is a , leptos, made by , of the hypothalamus , satiety hormone", that helps to regulate , thin", to regulate appetite to achieve , ό&sigmaf
Source proteins, Recombinants or rec
Grouprecombinants
Gene target(E, Coli) Leptin binding domain
Short nameColi) Purified Leptin binding domain, Recombinant (E
Technique E, adi advises they will be reconstituted in a buffer soluion or culture medium for cell culture, coli recombinant proteins are , supplied as white sterile powder lyopillized, Recombinant, genetic recombinations , in Escherichia coli
Species Humans, Human
Alternative name sapiens recombinant (Escherichia Coli) enriched Leptin binding domain, H
Alternative techniquerec

Similar products

Subscribe to our Newsletter